Clinical Trial Update: Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study at Beth Israel Deaconess Medical Center is evaluating androgen receptor signaling and PSMA expression in prostate cancer. The trial is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Prostate Adenocarcinoma, Prostate Cancer | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING